ODN 1668
Modify Date: 2024-01-11 13:28:50
ODN 1668 structure
|
Common Name | ODN 1668 | ||
|---|---|---|---|---|
| CAS Number | 1186063-66-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ODN 1668ODN 1668, a class B CpG ODN (oligodeoxynucleotide), is a TLR-9 agonist. ODN 1668 is an immunostimulatory sequence and can be used as vaccine adjuvant. Sequence: 5'-tccatgacgttcctgatgct-3’[1][2]. |
| Name | ODN 1668 |
|---|
| Description | ODN 1668, a class B CpG ODN (oligodeoxynucleotide), is a TLR-9 agonist. ODN 1668 is an immunostimulatory sequence and can be used as vaccine adjuvant. Sequence: 5'-tccatgacgttcctgatgct-3’[1][2]. |
|---|---|
| Related Catalog | |
| Target |
TLR9 |
| In Vitro | ODN 1668 induces TNF-α secretion and promotes polyclonal B cell activation[1]. |
| In Vivo | ODN 1668 (10 nmol) stimulates responses to protein antigen[1]. ODN 1668 (1 or 5 mg/kg; i.p. or s.c.; once) causes moderate fever and anorexia in rats[2]. Animal Model: C57BW6 mice[1] Dosage: 10 nmol Administration: 300 μg OVA (ovalbumin) in PBS or liposomes containing OVA were injected with or without 10nmol ODN in the hind footpads of C57BW6 mice. A boost of the sameinoculum was given at 2 weeks, and 1 week later blood was taken for serum antibody titering. Result: Strongly potentiated the antibody response and induced class switching toward IgG2a and IgG2b. Showed B cell blast formation and a more than twofold increase in B7.2 (CD86) and IL-2 receptor-α (CD25) surface expression. Animal Model: Male Wistar rats with body weights in the range of 175–200 g[2] Dosage: 1 mg/kg or 5 mg/kg Administration: Intraperitoneal and subcutaneous injection, once Result: Caused moderate fever and anorexia. Induced a significant increase of IL-6. Increased expression of inflammatory genes and activated inflammatory transcription factors. |
| References |
| No Any Chemical & Physical Properties |